U.S. to buy 1.4 million more courses of Merck’s COVID-19 pill -Breaking
[ad_1]
(Reuters) -Merck & Co Inc and partner Ridgeback Biotherapeutics said on Tuesday the U.S. government would buy an additional 1.4 million courses of their COVID-19 pill, molnupiravir.
In June, the U.S. Government agreed to invest $1.2 billion in 1.7 Million Courses.
According to the companies, the government has options for buying additional doses. The contract is valued at $2.2 billion, or 3.1 million courses.
They also mentioned that the U.S. government has additional options for purchasing more than 2,000,000 courses as part of this contract.
Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.
[ad_2]